Cardiopulmonary Bypass System Market Demand to 2033

Cardiopulmonary Bypass System Market Outlook (2023 to 2033)

The net worth of the total cardiopulmonary bypass systems sold globally was estimated to be around US$ 173.9 million back in the year 2018. The global cardiopulmonary bypass system market is forecasted to be appraised at US$ 270.9 million by 2033, up from US$ 197.3 million in 2023, advancing at a CAGR of 3.2% during the forecast period.

The rising healthcare expenditure to curb serious illnesses, such as cardiac diseases, is estimated to drive the demand for cardiopulmonary bypass systems. However, adverse side effects as a result of bypass procedures are likely to curb the adoption of these systems. Conversely, the fast-growing technological developments and increasing count of surgical procedures are expected to stimulate market advancement and issue creative options for market players.

The roller cardiopulmonary bypass pumps in the overall market share are likely to expand owing to their advantages. These include lower costs, simplicity, ease of use, reliability of flow calculation, and increased resistance without reducing flow.

Primary or secondary pulmonary hypertension is growing in lung transplantation procedures. The systems have witnessed an increasing penetration in en-bloc double-lung transplantation. These factors are likely to greatly contribute to the market's key trends and opportunities.

Due to continual monitoring of line or circuit pressure, temperature, blood parameters, and safety features, modern cardiopulmonary bypass systems are increasingly being used in hospitals. Furthermore, a growth in cardiovascular procedures are increasing product penetration and is anticipated to bolster the total market growth.

Report Attributes or Data Points	Details
Global Cardiopulmonary Bypass System Market Valuation in 2022	US$ 192.4 million
Estimated Global Market Share in 2023	US$ 197.3 million
Forecasted Global Market Size by 2033	US$ 270.9 million
Projected Global Market Growth Rate from 2023 to 2033	3.2% CAGR
Historical Market Growth Rate from 2018 to 2022	2% CAGR

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Growth Influencers of the Cardiopulmonary Bypass System Market

One of the most pivotal drivers that govern the acceleration of the global market share is the growing geriatric population. Moreover, the increase in the prevalence of cardiovascular diseases, such as supraventricular tachycardia, atrial fibrillation, atrial flutter, etc., surges a serious demand for cardiopulmonary bypass.

Due to changing lifestyles, a lot of cardiac issues come into question. These include a decrease in heart muscle elasticity or a decrease in heart output. These concerns demand the rapid deployment of cardiopulmonary bypass systems. Unhealthy dietary habits coupled with a lack of proper exercise practiced for a prolonged period can increase the occurrences of heart-related diseases, such as heart failure. These factors are likely to propel the demand and boost the cardiopulmonary bypass system market size.

Sedentary lifestyles and increasing stress issues due to extensive workload can negatively impact the heart in the long run. These factors, along with an increase in organ transplant surgeries, are likely to surge the deployment of cardiopulmonary bypass systems eventually.

The cardiopulmonary bypass systems market has witnessed stringent government regulations, which is a key challenge, along with the recall of the components of cardiopulmonary bypass equipment. Additionally, a shortage of skilled professionals able to perform heart- or lung-related procedures is likely to obstruct the growth of the market.

Rising cases of cardiac illnesses are increasing the awareness of the benefits of cardiopulmonary bypass systems, which is likely to generate lucrative opportunities for the market and secure its advancement. Moreover, medical tourism growing in popularity is expected to create numerous scopes for manufacturers and increase sales of the cardiopulmonary bypass system.

Regional Market Comparison	Global Market Share in Percentage
North America	37.2%
Europe	27.3%

What is the Regional Analysis of the Cardiopulmonary Bypass System Market?

North America is the leading market, with a significant revenue share of 30.6% in 2022. This is attributed to the high healthcare infrastructure and favorable reimbursement scenario.

Increasing technological development of cardiopulmonary bypass accessory equipment, owing to the presence of the largest customer base with high GDP, is estimated to contribute to the market growth significantly. Furthermore, rising cases of cardiovascular diseases in this region are likely to further contribute to the expansion of the overall market size.

Regional Market Comparison	Global Market Share in Percentage
United States	33.5%
Germany	5.8%
Japan	3.6%

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

How is the Start-up Ecosystem in the Cardiopulmonary Bypass System Market?

Chronic cardiovascular cases are rising across the globe and require improved surgical procedures. Manufacturers are incorporating contemporary strategies to enhance their presence in the market. This includes adopting both organic and inorganic growth strategies, such as acquisitions and new product launches, to garner a higher market share.

Start-up companies are applying their strategies to contribute to market growth. This is likely to advance their presence in the market, as well as improve cardiovascular disease treatments.

Ventura Medical is developing a catheter-based heart pump to provide cardiac support to patients in need of cardiopulmonary support. According to Venstra Medical, the temporary device may allow cardiologists to provide patients in need of cardiac support with a treatment option that does not require surgical intervention.

Regional Markets	CAGR (2023 to 2033)
United Kingdom	2.3%
China	3.9%
India	3.2%
Australia	2.8%

Top 5 Key Companies Transforming the Cardiopulmonary Bypass System Market Space

Key manufacturers are primarily focusing on providing innovative products to various hospitals through collaborative relationships or mergers. This is because this market is especially technology-driven and is strengthened by constant product innovations.

Key market participants of the cardiopulmonary bypass system market:

LivaNova PLC (Sorin Group) - They are a medical products group based in Italy, with significant operations in France, the USA, and Japan, specializing in cardiac devices. Their product lines include replacement heart valves, oxygenators, perfusion tubing sets, cardiothoracic surgery accessories, data monitoring, heart-lung machines, autotransfusion systems, cannulae, and blood management products.
Abbott Laboratories is an American multinational medical device and health care company headquartered in Abbott Park, Illinois, USA. The company was founded by Chicago physician Wallace Calvin Abbott in 1888 to formulate known drugs; today, it sells medical devices, diagnostics, branded generic medicines, and nutritional products.
Braile Biomedica - Unique in the segment with 100% Brazilian technology, they develop over 400 products in the Cardiovascular, Electromechanical, Biological & Solutions, and Endovascular divisions.
Spectrum Medical - They supply clinical information solutions, including medical device connectivity technologies, electronic medical record systems, telemedicine capabilities, and compliance and patient safety solutions. Spectrum Medical also supplies Non-invasive Diagnostics Systems for extracorporeal procedures.
Medtronic plc. - They are an American medical device company based in Ireland for tax purposes and a global leader in medical technology, services, and solutions. The company primarily operates in the United States. Medtronic has an operational and executive headquarters in Minneapolis, Minnesota, in the United States.

Category	By Product Type
Top Segment	Conventional
Market Share in Percentage	63.8%

Category	By End User
Top Segment	Hospital
Market Share in Percentage	44.7%

Other Market Participants of the Cardiopulmonary Bypass System Market

Minnetronix Inc.
Transonic
MAQUET Holding B.V. & Co. KG.
Getinge AB
Terumo Corporation
MicroPort Scientific Corporation
Xenios AG
Nipro Corporation
Eurosets Srl
OriGen Biomedical
Thoratec Corporation
Tianjin Medical
Olympus Corporation
Haemonetics Corporation

Some Recent Developments in the Cardiopulmonary Bypass System Market are:

In June 2014, Sorin Group celebrated the delivery of its 10,000th heart-lung machine (S5 heart-lung machine) to Brigham and Women's Hospital, Boston, MA, USA. Thuse achieved an exciting milestone that reflects the tremendous trust and collaborative partnership with their customers worldwide.
In October 2021, MicroPort acquired 100% of the equity held by existing shareholders of Hemovent GmbH. Hemovent specializes in the development of ground-breaking Extracorporeal Life Support (ECLS) systems.
In February 2022, Getinge acquired 100% of the equity interest in Talis Clinical LLC, a US-based leading innovator of High Acuity cloud-based software solutions. Talis Clinical’s offer is designed to support and document care throughout the general and cardiac perioperative care process, but also through labor and delivery episodes and critical care support, including ECMO Therapy.
In April 2022, LivaNova initiated the targeted commercial launch of Essenz™. Patient Monitor for cardiopulmonary bypass procedures. The transformative monitoring system uses a patient-tailored approach to improve clinical efficiency and quality of patient care during cardiopulmonary bypass (CPB) procedures.
In January 2021, Eurosets announced the full commercial release (out of the USA) of its novel ECMOlife system for Extracorporeal Life Support (ECLS). ECMOlife expands Eurosets' portfolio to temporarily support patients in different therapeutic areas, including Extracorporeal Membrane Oxygenation (ECMO) and Mechanical Circulatory Support (MCS).

Report Scope

Report Attributes	Details
Growth Rate	CAGR of 3.2% from 2022 to 2032
The base year for estimation	2022
Historical data	2018 to 2022
Forecast period	2023 to 2033
Quantitative units	Revenue in US$ million and CAGR from 2023 to 2033
Report Coverage	Revenue forecast, volume forecast, company ranking, competitive landscape, growth factors and trends, Pricing Analysis,
Segments Covered	Product Type, Modality, End User, and Region.
Regional scope	North America; Western Europe, Eastern Europe, Middle East, Africa, ASEAN, South Asia, Rest of Asia, Australia, and New Zealand
Country scope	USA; Canada; Mexico; Germany; United Kingdom; France; Italy; Spain; Russia; Belgium; Poland; Czech Republic; China; India; Japan; Australia; Brazil; Argentina; Colombia; Saudi Arabia; United Arab Emirates; Iran; South Africa
Key companies profiled	LivaNova PLC (Sorin Group), Abbott Laboratories, Braile Biomedica, Spectrum Medical, Minnetronix Inc., Transonic, Medtronic plc., MAQUET Holding B.V. & Co. KG, Getinge AB, Terumo Corporation, MicroPort Scientific Corporation, Xenios AG, Nipro Corporation, Eurosets Srl, OriGen Biomedical, Thoratec Corporation, Tianjin Medical, Olympus Corporation, Haemonetics Corporation, etc.
Customization scope	Free report customization (equivalent to 8 analysts' working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs.

Key Segments Profiled in the Cardiopulmonary Bypass System Industry Survey Report

By Product Type:

Conventional
Mini

By Modality:

Standalone
Portable

By End User:

Hospitals
Ambulatory Surgical Centers
Cardiac Research Centers

By Region:

North America
Latin America
Asia Pacific
The Middle East and Africa
Europe

Frequently Asked Questions

What is the Cardiopulmonary Bypass System Market Value in 2023?

The market in 2023 is valued at US$ 197.3 million.

What is the expected market value in 2033?

The market will reach US$ 270.9 million by 2033.

What is the likely CAGR until 2033?

The market will register a 3.2% CAGR until 2033.

What was the market’s historical performance?

From 2018 to 2022, the market expanded at a 2% CAGR.

Who are some key market players?

Minnetronix Inc., Transonic, and MAQUET Holding B.V. & Co. KG are some key players.

Table of Content

1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Product Type, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product Type, 2023 to 2033
5.3.1. Conventional
5.3.2. Mini
5.4. Y-o-Y Growth Trend Analysis By Product Type, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Product Type, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Modality
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By Modality, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Modality, 2023 to 2033
6.3.1. Standalone
6.3.2. Portable
6.4. Y-o-Y Growth Trend Analysis By Modality, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By Modality, 2023 to 2033
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) Analysis By End User , 2018 to 2022
7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User , 2023 to 2033
7.3.1. Hospitals
7.3.2. Ambulatory Surgical Centers
7.3.3. Cardiac Research Centers
7.4. Y-o-Y Growth Trend Analysis By End User , 2018 to 2022
7.5. Absolute $ Opportunity Analysis By End User , 2023 to 2033
8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022
8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033
8.3.1. North America
8.3.2. Latin America
8.3.3. Western Europe
8.3.4. Eastern Europe
8.3.5. South Asia and Pacific
8.3.6. East Asia
8.3.7. Middle East and Africa
8.4. Market Attractiveness Analysis By Region
9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. USA.
9.2.1.2. Canada
9.2.2. By Product Type
9.2.3. By Modality
9.2.4. By End User
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Product Type
9.3.3. By Modality
9.3.4. By End User
9.4. Key Takeaways
10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Rest of Latin America
10.2.2. By Product Type
10.2.3. By Modality
10.2.4. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product Type
10.3.3. By Modality
10.3.4. By End User
10.4. Key Takeaways
11. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. United Kingdom.
11.2.1.3. France
11.2.1.4. Spain
11.2.1.5. Italy
11.2.1.6. Rest of Western Europe
11.2.2. By Product Type
11.2.3. By Modality
11.2.4. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product Type
11.3.3. By Modality
11.3.4. By End User
11.4. Key Takeaways
12. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. Poland
12.2.1.2. Russia
12.2.1.3. Czech Republic
12.2.1.4. Romania
12.2.1.5. Rest of Eastern Europe
12.2.2. By Product Type
12.2.3. By Modality
12.2.4. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product Type
12.3.3. By Modality
12.3.4. By End User
12.4. Key Takeaways
13. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. India
13.2.1.2. Bangladesh
13.2.1.3. Australia
13.2.1.4. New Zealand
13.2.1.5. Rest of South Asia and Pacific
13.2.2. By Product Type
13.2.3. By Modality
13.2.4. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product Type
13.3.3. By Modality
13.3.4. By End User
13.4. Key Takeaways
14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Country
14.2.1.1. China
14.2.1.2. Japan
14.2.1.3. South Korea
14.2.2. By Product Type
14.2.3. By Modality
14.2.4. By End User
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Product Type
14.3.3. By Modality
14.3.4. By End User
14.4. Key Takeaways
15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
15.2.1. By Country
15.2.1.1. GCC Countries
15.2.1.2. South Africa
15.2.1.3. Israel
15.2.1.4. Rest of MEA
15.2.2. By Product Type
15.2.3. By Modality
15.2.4. By End User
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Product Type
15.3.3. By Modality
15.3.4. By End User
15.4. Key Takeaways
16. Key Countries Market Analysis
16.1. USA.
16.1.1. Pricing Analysis
16.1.2. Market Share Analysis, 2022
16.1.2.1. By Product Type
16.1.2.2. By Modality
16.1.2.3. By End User
16.2. Canada
16.2.1. Pricing Analysis
16.2.2. Market Share Analysis, 2022
16.2.2.1. By Product Type
16.2.2.2. By Modality
16.2.2.3. By End User
16.3. Brazil
16.3.1. Pricing Analysis
16.3.2. Market Share Analysis, 2022
16.3.2.1. By Product Type
16.3.2.2. By Modality
16.3.2.3. By End User
16.4. Mexico
16.4.1. Pricing Analysis
16.4.2. Market Share Analysis, 2022
16.4.2.1. By Product Type
16.4.2.2. By Modality
16.4.2.3. By End User
16.5. Germany
16.5.1. Pricing Analysis
16.5.2. Market Share Analysis, 2022
16.5.2.1. By Product Type
16.5.2.2. By Modality
16.5.2.3. By End User
16.6. United Kingdom.
16.6.1. Pricing Analysis
16.6.2. Market Share Analysis, 2022
16.6.2.1. By Product Type
16.6.2.2. By Modality
16.6.2.3. By End User
16.7. France
16.7.1. Pricing Analysis
16.7.2. Market Share Analysis, 2022
16.7.2.1. By Product Type
16.7.2.2. By Modality
16.7.2.3. By End User
16.8. Spain
16.8.1. Pricing Analysis
16.8.2. Market Share Analysis, 2022
16.8.2.1. By Product Type
16.8.2.2. By Modality
16.8.2.3. By End User
16.9. Italy
16.9.1. Pricing Analysis
16.9.2. Market Share Analysis, 2022
16.9.2.1. By Product Type
16.9.2.2. By Modality
16.9.2.3. By End User
16.10. Poland
16.10.1. Pricing Analysis
16.10.2. Market Share Analysis, 2022
16.10.2.1. By Product Type
16.10.2.2. By Modality
16.10.2.3. By End User
16.11. Russia
16.11.1. Pricing Analysis
16.11.2. Market Share Analysis, 2022
16.11.2.1. By Product Type
16.11.2.2. By Modality
16.11.2.3. By End User
16.12. Czech Republic
16.12.1. Pricing Analysis
16.12.2. Market Share Analysis, 2022
16.12.2.1. By Product Type
16.12.2.2. By Modality
16.12.2.3. By End User
16.13. Romania
16.13.1. Pricing Analysis
16.13.2. Market Share Analysis, 2022
16.13.2.1. By Product Type
16.13.2.2. By Modality
16.13.2.3. By End User
16.14. India
16.14.1. Pricing Analysis
16.14.2. Market Share Analysis, 2022
16.14.2.1. By Product Type
16.14.2.2. By Modality
16.14.2.3. By End User
16.15. Bangladesh
16.15.1. Pricing Analysis
16.15.2. Market Share Analysis, 2022
16.15.2.1. By Product Type
16.15.2.2. By Modality
16.15.2.3. By End User
16.16. Australia
16.16.1. Pricing Analysis
16.16.2. Market Share Analysis, 2022
16.16.2.1. By Product Type
16.16.2.2. By Modality
16.16.2.3. By End User
16.17. New Zealand
16.17.1. Pricing Analysis
16.17.2. Market Share Analysis, 2022
16.17.2.1. By Product Type
16.17.2.2. By Modality
16.17.2.3. By End User
16.18. China
16.18.1. Pricing Analysis
16.18.2. Market Share Analysis, 2022
16.18.2.1. By Product Type
16.18.2.2. By Modality
16.18.2.3. By End User
16.19. Japan
16.19.1. Pricing Analysis
16.19.2. Market Share Analysis, 2022
16.19.2.1. By Product Type
16.19.2.2. By Modality
16.19.2.3. By End User
16.20. South Korea
16.20.1. Pricing Analysis
16.20.2. Market Share Analysis, 2022
16.20.2.1. By Product Type
16.20.2.2. By Modality
16.20.2.3. By End User
16.21. GCC Countries
16.21.1. Pricing Analysis
16.21.2. Market Share Analysis, 2022
16.21.2.1. By Product Type
16.21.2.2. By Modality
16.21.2.3. By End User
16.22. South Africa
16.22.1. Pricing Analysis
16.22.2. Market Share Analysis, 2022
16.22.2.1. By Product Type
16.22.2.2. By Modality
16.22.2.3. By End User
16.23. Israel
16.23.1. Pricing Analysis
16.23.2. Market Share Analysis, 2022
16.23.2.1. By Product Type
16.23.2.2. By Modality
16.23.2.3. By End User
17. Market Structure Analysis
17.1. Competition Dashboard
17.2. Competition Benchmarking
17.3. Market Share Analysis of Top Players
17.3.1. By Regional
17.3.2. By Product Type
17.3.3. By Modality
17.3.4. By End User
18. Competition Analysis
18.1. Competition Deep Dive
18.1.1. Minnetronix Inc.
18.1.1.1. Overview
18.1.1.2. Product Portfolio
18.1.1.3. Profitability by Market Segments
18.1.1.4. Sales Footprint
18.1.1.5. Strategy Overview
18.1.1.5.1. Marketing Strategy
18.1.2. Transonic
18.1.2.1. Overview
18.1.2.2. Product Portfolio
18.1.2.3. Profitability by Market Segments
18.1.2.4. Sales Footprint
18.1.2.5. Strategy Overview
18.1.2.5.1. Marketing Strategy
18.1.3. MAQUET Holding B.V. & Co. KG.
18.1.3.1. Overview
18.1.3.2. Product Portfolio
18.1.3.3. Profitability by Market Segments
18.1.3.4. Sales Footprint
18.1.3.5. Strategy Overview
18.1.3.5.1. Marketing Strategy
18.1.4. Getinge AB
18.1.4.1. Overview
18.1.4.2. Product Portfolio
18.1.4.3. Profitability by Market Segments
18.1.4.4. Sales Footprint
18.1.4.5. Strategy Overview
18.1.4.5.1. Marketing Strategy
18.1.5. Terumo Corporation
18.1.5.1. Overview
18.1.5.2. Product Portfolio
18.1.5.3. Profitability by Market Segments
18.1.5.4. Sales Footprint
18.1.5.5. Strategy Overview
18.1.5.5.1. Marketing Strategy
18.1.6. MicroPort Scientific Corporation
18.1.6.1. Overview
18.1.6.2. Product Portfolio
18.1.6.3. Profitability by Market Segments
18.1.6.4. Sales Footprint
18.1.6.5. Strategy Overview
18.1.6.5.1. Marketing Strategy
18.1.7. Xenios AG
18.1.7.1. Overview
18.1.7.2. Product Portfolio
18.1.7.3. Profitability by Market Segments
18.1.7.4. Sales Footprint
18.1.7.5. Strategy Overview
18.1.7.5.1. Marketing Strategy
18.1.8. Nipro Corporation
18.1.8.1. Overview
18.1.8.2. Product Portfolio
18.1.8.3. Profitability by Market Segments
18.1.8.4. Sales Footprint
18.1.8.5. Strategy Overview
18.1.8.5.1. Marketing Strategy
18.1.9. Eurosets Srl
18.1.9.1. Overview
18.1.9.2. Product Portfolio
18.1.9.3. Profitability by Market Segments
18.1.9.4. Sales Footprint
18.1.9.5. Strategy Overview
18.1.9.5.1. Marketing Strategy
18.1.10. OriGen Biomedical
18.1.10.1. Overview
18.1.10.2. Product Portfolio
18.1.10.3. Profitability by Market Segments
18.1.10.4. Sales Footprint
18.1.10.5. Strategy Overview
18.1.10.5.1. Marketing Strategy
18.1.11. Thoratec Corporation
18.1.11.1. Overview
18.1.11.2. Product Portfolio
18.1.11.3. Profitability by Market Segments
18.1.11.4. Sales Footprint
18.1.11.5. Strategy Overview
18.1.11.5.1. Marketing Strategy
18.1.12. Tianjin Medical
18.1.12.1. Overview
18.1.12.2. Product Portfolio
18.1.12.3. Profitability by Market Segments
18.1.12.4. Sales Footprint
18.1.12.5. Strategy Overview
18.1.12.5.1. Marketing Strategy
18.1.13. Olympus Corporation
18.1.13.1. Overview
18.1.13.2. Product Portfolio
18.1.13.3. Profitability by Market Segments
18.1.13.4. Sales Footprint
18.1.13.5. Strategy Overview
18.1.13.5.1. Marketing Strategy
18.1.14. Haemonetics Corporation
18.1.14.1. Overview
18.1.14.2. Product Portfolio
18.1.14.3. Profitability by Market Segments
18.1.14.4. Sales Footprint
18.1.14.5. Strategy Overview
18.1.14.5.1. Marketing Strategy
19. Assumptions & Acronyms Used
20. Research Methodology

Cardiopulmonary Bypass System Market

Analysis of Cardiopulmonary Bypass System Market by Standalone and Portable Modality Types